Quick Answer
ELITE PHARMACEUTICALS INC /NV/ reported Net Income of -$4.31 million for fiscal year 2025.
ELITE PHARMACEUTICALS INC /NV/ Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$4.31M | -121.5% |
| 2024 | $20.11M | +464.6% |
| 2023 | $3.56M | -60.0% |
| 2022 | $8.90M | +74.9% |
| 2021 | $5.09M | +327.1% |
| 2020 | -$2.24M | +75.9% |
| 2019 | -$9.28M | -152.6% |
| 2018 | -$3.67M | -196.4% |
| 2017 | $3.81M | +658.0% |
| 2016 | -$683.0K | -113.1% |
| 2015 | $5.22M | +112.7% |
| 2014 | -$41.26M | -2873.0% |
| 2013 | $1.49M | +109.9% |
| 2012 | -$15.06M | -10.9% |
| 2011 | -$13.58M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $18.59M | +270.7% | +35.7% |
| September 30, 2025 | $13.70M | +224.2% | +332.8% |
| June 30, 2025 | -$5.88M | -1055.7% | +46.0% |
| December 31, 2024 | -$10.89M | -1642.0% | +1.3% |
| September 30, 2024 | -$11.04M | -173.9% | -1892.3% |
| June 30, 2024 | $615.8K | -46.1% | -12.8% |
| December 31, 2023 | $706.4K | -76.2% | -95.3% |
| September 30, 2023 | $14.93M | +885.7% | +1208.0% |
- ELITE PHARMACEUTICALS INC /NV/ showed a decrease of -121.5% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, ELITE PHARMACEUTICALS INC /NV/’s net income has grown by 68.2% (from -$13.58 million to -$4.31 million).
- The most recent figure is from ELITE PHARMACEUTICALS INC /NV/’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: